Hereditary cancer predisposition syndromes.
暂无分享,去创建一个
[1] W. Kaelin,et al. von Hippel-Lindau disease. , 1997, Medicine.
[2] W. Foulkes,et al. Familial Adenomatous Polyposis , 2006, The American Journal of Gastroenterology.
[3] K. Offit. MSH6 mutations in hereditary nonpolyposis colon cancer: another slice of the pie. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] B. Dallapiccola,et al. Spectrum of PTCH mutations in Italian nevoid basal cell‐carcinoma syndrome patients: Identification of thirteen novel alleles , 2004, Human mutation.
[5] K. Offit,et al. Breast MRI for women with hereditary cancer risk. , 2004, JAMA.
[6] Ellen Warner,et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.
[7] W. Foulkes,et al. BRCA1 and BRCA2: 1994 and beyond , 2004, Nature Reviews Cancer.
[8] C. Eng,et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.
[9] B. Gallie,et al. Retinoblastoma: Revisiting the model prototype of inherited cancer , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.
[10] M. Leppert,et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. , 2004, Gastroenterology.
[11] H. D. de Koning,et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.
[12] W. Foulkes,et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.
[13] E. Jordanova,et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families , 2004, Oncogene.
[14] S. Leachman,et al. Clinical germline genetic testing for melanoma. , 2004, The Lancet. Oncology.
[15] K. Offit,et al. BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews , 2004, Clinical Cancer Research.
[16] Jakub Tolar,et al. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. , 2004, Blood.
[17] Alison P. Klein,et al. Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds , 2004, Cancer Research.
[18] J. Klijn,et al. Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers , 2004, Clinical Cancer Research.
[19] D. Easton,et al. Lifetime risks of common cancers among retinoblastoma survivors. , 2004, Journal of the National Cancer Institute.
[20] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[21] P. Guilford,et al. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone , 2003, Gut.
[22] L. Kiemeney,et al. Genetic susceptibility to prostate cancer: a review , 2004, Familial Cancer.
[23] C. Kuhl,et al. Surveillance of "high risk" women with proven or suspected familial (hereditary) breast cancer: First mid-term results of a multi-modality clinical screening trial , 2003 .
[24] F. Graziano,et al. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] K. Offit,et al. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] M. King,et al. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.
[27] Kenneth Offit,et al. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. , 2003, Journal of the National Cancer Institute.
[28] K. Nathanson,et al. Pheochromocytoma: the expanding genetic differential diagnosis. , 2003, Journal of the National Cancer Institute.
[29] Michael M Lieber,et al. The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.
[30] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] Adopted on March. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] R. R. Lonser,et al. von Hippel-Lindau disease , 2003, The Lancet.
[33] R. Hruban,et al. Fanconi anemia gene mutations in young-onset pancreatic cancer. , 2003, Cancer research.
[34] P. Radice,et al. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] R. L. Baldwin,et al. Improved survival in women with BRCA‐associated ovarian carcinoma , 2003, Cancer.
[36] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[37] P. Pharoah,et al. Prediction of pathogenic mutations in patients with early-onset breast cancer by family history , 2003, The Lancet.
[38] J. Varley. Germline TP53 mutations and Li‐Fraumeni syndrome , 2003, Human mutation.
[39] J. Gray,et al. The genetics and genomics of cancer , 2003, Nature Genetics.
[40] L. Lipton,et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. , 2003, The New England journal of medicine.
[41] Marianne Berwick,et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). , 2003, Blood.
[42] A. Ziegler,et al. BRCA2 germline mutations in familial pancreatic carcinoma. , 2003, Journal of the National Cancer Institute.
[43] R. Hruban,et al. Familial pancreatic cancer: where are we in 2003? , 2003, Journal of the National Cancer Institute.
[44] M. Claustres,et al. First preimplantation genetic diagnosis of hereditary retinoblastoma using informative microsatellite markers. , 2003, Molecular human reproduction.
[45] J. Varley. TP53, hChk2, and the Li-Fraumeni syndrome. , 2003, Methods in molecular biology.
[46] L. Strong. General keynote: hereditary cancer: lessons from Li-Fraumeni syndrome. , 2003, Gynecologic oncology.
[47] F. Couch,et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. , 2002, Journal of the National Cancer Institute.
[48] C. Eng,et al. The pressure rises: update on the genetics of phaeochromocytoma. , 2002, Human molecular genetics.
[49] O. Bratt. Hereditary prostate cancer: clinical aspects. , 2002, The Journal of urology.
[50] C. Begg. On the use of familial aggregation in population-based case probands for calculating penetrance. , 2002, Journal of the National Cancer Institute.
[51] T. Beaty,et al. Evidence for a major gene influencing risk of pancreatic cancer , 2002, Genetic epidemiology.
[52] G. Parmigiani,et al. Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families , 2002, Journal of medical genetics.
[53] Kathleen M Murphy,et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. , 2002, Cancer research.
[54] Florence Demenais,et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. , 2002, Journal of the National Cancer Institute.
[55] Hans Joenje,et al. Biallelic Inactivation of BRCA2 in Fanconi Anemia , 2002, Science.
[56] C. Eng. Role of PTEN, a Lipid Phosphatase Upstream Effector of Protein Kinase B, in Epithelial Thyroid Carcinogenesis , 2002, Annals of the New York Academy of Sciences.
[57] B. Levin,et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis , 2002, Gut.
[58] J. Satagopan,et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. , 2002, The New England journal of medicine.
[59] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[60] J. Schipper,et al. Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.
[61] S. Piantadosi,et al. Primary chemoprevention of familial adenomatous polyposis with sulindac , 2002 .
[62] Leonid Kruglyak,et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. , 2002, American journal of human genetics.
[63] Sean V Tavtigian,et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[64] Douglas F. Easton,et al. Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.
[65] R. Peek,et al. Hereditary diffuse gastric cancer: more answers or more questions? , 2002, Gastroenterology.
[66] Daniel J Sargent,et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] J. Church,et al. Attenuated Familial Adenomatous Polyposis , 2002, Diseases of the colon and rectum.
[68] S. Rechitsky,et al. Preimplantation genetic diagnosis for cancer predisposition. , 2002, Reproductive biomedicine online.
[69] R. Hruban,et al. Familial pancreatic cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[70] John P. Bilezikian,et al. CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 , 2001 .
[71] T. Sellers,et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. , 2001, Journal of the National Cancer Institute.
[72] J. Harbour,et al. Molecular basis of low-penetrance retinoblastoma. , 2001, Archives of ophthalmology.
[73] K. Kinzler,et al. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. , 2001, Cancer research.
[74] D. Schaid,et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. , 2001, American journal of human genetics.
[75] T. Dryja,et al. RB1 genetic testing as a clinical service: a follow-up study. , 2001, Medical and pediatric oncology.
[76] S Wacholder,et al. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. , 2001, The New England journal of medicine.
[77] J. Klijn,et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. , 2001, The New England journal of medicine.
[78] B. Petersen,et al. Germline E‐cadherin gene mutations , 2001, Cancer.
[79] G. Petersen,et al. AGA technical review on hereditary colorectal cancer and genetic testing. , 2001, Gastroenterology.
[80] C. Caldas,et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. , 2001, The New England journal of medicine.
[81] L. McCahill,et al. The power of genetics to target surgical prevention. , 2001, The New England journal of medicine.
[82] P. Lynch. COX-2 inhibition in clinical cancer prevention. , 2001, Oncology.
[83] S. Olschwang,et al. Familial Adenomatous Polyposis: Prevalence of Adenomas in the Ileal Pouch After Restorative Proctocolectomy , 2001, Annals of surgery.
[84] B. Rosen,et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. , 2001, American journal of human genetics.
[85] O. Olopade,et al. Male breast cancer in Cowden syndrome patients with germlinePTEN mutations , 2001, Journal of medical genetics.
[86] W. Linehan,et al. Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma , 2001, Annals of Internal Medicine.
[87] J. Fraumeni,et al. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[88] D. Easton,et al. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. , 2001, American journal of human genetics.
[89] S. Ganesan,et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.
[90] K. Heimdal,et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.
[91] M. Choti,et al. NCCN Practice Guidelines for Colorectal Cancer. , 2000, Oncology.
[92] T. Powles,et al. Chemoprevention options for BRCA1 and BRCA2 mutation carriers. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[93] C. Eng. Will the real Cowden syndrome please stand up: revised diagnostic criteria , 2000, Journal of medical genetics.
[94] B. Weber,et al. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. , 2000, American journal of human genetics.
[95] N. Gruis,et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16‐Leiden) , 2000, International journal of cancer.
[96] J. Garber,et al. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. , 2000, JAMA.
[97] Å. Borg,et al. High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma Families , 2000 .
[98] H. Hampel,et al. Hereditary colorectal cancer: risk assessment and management , 2000, Clinical genetics.
[99] P. Chappuis,et al. Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer. , 2000, Seminars in surgical oncology.
[100] J. Boyd,et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. , 2000, JAMA.
[101] L. Aaltonen,et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.
[102] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[103] S. Gallinger,et al. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. , 2000, Cancer research.
[104] D. Ahlquist,et al. Care of patients and their families with familial adenomatous polyposis. , 2000, Mayo Clinic proceedings.
[105] K. Isselbacher,et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.
[106] I. Andrulis,et al. Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[107] P. Choyke,et al. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. , 1999, The Journal of urology.
[108] C Eng,et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. , 1999, Human molecular genetics.
[109] W. Linehan,et al. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. , 1999, The New England journal of medicine.
[110] H T Lynch,et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.
[111] L. Aaltonen,et al. Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.
[112] S. Markowitz,et al. E‐cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer , 1999, Human mutation.
[113] H. Olsson. Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.
[114] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[115] D. Birnbaum,et al. BRCA1 and medullary breast cancer. , 1998, JAMA.
[116] D. Evans,et al. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li–Fraumeni syndrome , 1998, Oncogene.
[117] A. Zwinderman,et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. , 1998, The New England journal of medicine.
[118] B. Ponder,et al. Oral Contraceptives and the Risk of Hereditary Ovarian Cancer , 1998 .
[119] S N Thibodeau,et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. , 1998, Cancer research.
[120] P. Boyle,et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women , 1998, The Lancet.
[121] D. Albert,et al. Trilateral retinoblastoma: insights into histogenesis and management. , 1998, Survey of ophthalmology.
[122] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[123] C. Boland,et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.
[124] H. Ostrer,et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC , 1997, Nature Genetics.
[125] B. Gallie. Predictive testing for retinoblastoma comes of age. , 1997, American journal of human genetics.
[126] B. Lorenz,et al. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. , 1997, American journal of human genetics.
[127] B. Ponder,et al. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. , 1997, Human molecular genetics.
[128] J. Eyfjörd,et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. , 1997, American journal of human genetics.
[129] G. Eichele,et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.
[130] Y Wang,et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.
[131] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[132] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .
[133] K Offit,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.
[134] E. Thomson,et al. Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer , 1997 .
[135] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. , 1997, JAMA.
[136] A S Whittemore,et al. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. , 1997, American journal of human genetics.
[137] G. Coetzee,et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. , 1997, Journal of the National Cancer Institute.
[138] G. Chenevix-Trench,et al. Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. , 1997, American journal of human genetics.
[139] J. Fraumeni,et al. Hereditary retinoblastoma, lipoma, and second primary cancers. , 1997, Journal of the National Cancer Institute.
[140] T. Smyrk,et al. An update of HNPCC (Lynch syndrome). , 1997, Cancer genetics and cytogenetics.
[141] D. Evans,et al. Li-Fraumeni syndrome--a molecular and clinical review. , 1997, British Journal of Cancer.
[142] D. Evans,et al. PATIENTS AND METHODS , 1981 .
[143] D A Meyers,et al. Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.
[144] C Eng,et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. , 1996, JAMA.
[145] J. Mohler,et al. Association of prostate cancer with vitamin D receptor gene polymorphism. , 1996, Cancer research.
[146] A. Detsky,et al. Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. , 1996, American journal of human genetics.
[147] M. Rodriguez-Bigas. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer: Has the time come? , 1996, Cancer.
[148] R. Myers,et al. Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.
[149] K. Kinzler,et al. Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients , 1996, Nature Medicine.
[150] J. Norton,et al. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. , 1996, Journal of pediatric surgery.
[151] N. Hayward,et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.
[152] D. Bentley,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.
[153] A M Goldstein,et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. , 1995, The New England journal of medicine.
[154] F. Nagengast,et al. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) , 1995, The Lancet.
[155] P. Sistonen,et al. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. , 1995, Gastroenterology.
[156] B. Ponder,et al. Prophylactic oophorectomy in inherited breast/ovarian cancer families. , 1995, Journal of the National Cancer Institute. Monographs.
[157] M. Skolnick,et al. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). , 1994, Cancer research.
[158] T. G. Parks,et al. Familial adenomatous polyposis , 1994, The British journal of surgery.
[159] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[160] A. Cats,et al. Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. , 1994, Gut.
[161] M. Skolnick,et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus , 1994, Nature Genetics.
[162] S. O. Krolls,et al. Malignant Potential of the Odontogenic Keratocyst , 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[163] D. Ward,et al. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.
[164] R. Thakker,et al. Multiple endocrine neoplasia type 1 (MEN1). , 1994, European journal of cancer.
[165] Robin J. Leach,et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.
[166] N. Copeland,et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.
[167] G. Thomas,et al. Alleles of the APC gene: An attenuated form of familial polyposis , 1993, Cell.
[168] C. Eng,et al. Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma , 1993 .
[169] D. Evans,et al. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. , 1993, Journal of medical genetics.
[170] S N Thibodeau,et al. Microsatellite instability in cancer of the proximal colon. , 1993, Science.
[171] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[172] A. Goodman,et al. The benefit and cost of prostate cancer early detection , 1993, CA: a cancer journal for clinicians.
[173] W. Clark,et al. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. , 1993, American journal of human genetics.
[174] H. Lynch,et al. Extracolonic cancer in hereditary nonpolyposis colorectal cancer , 1993 .
[175] M. Skolnick,et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. , 1992, Science.
[176] M. Skolnick,et al. A screening study of prostate cancer in high risk families. , 1992, Journal of Urology.
[177] R. Weichselbaum,et al. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. , 1992, The New England journal of medicine.
[178] S. S. Kroll,et al. Primary breast cancer after prophylactic mastectomy. , 1991, American journal of clinical oncology.
[179] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[180] H T Lynch,et al. Hereditary colorectal cancer. , 1991, Seminars in oncology.
[181] H. Vasen,et al. Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands. , 1989, Archives of internal medicine.
[182] P. Green,et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. , 1989, The New England journal of medicine.
[183] W. Blattner,et al. A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.
[184] Robert J. Gorlin,et al. Nevoid Basal‐Cell Carcinoma Syndrome , 1987, Medicine.
[185] Stephen H. Friend,et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.
[186] A. Hover,et al. Cowden disease. A hereditary polyposis syndrome diagnosable by mucocutaneous inspection. , 1986, Journal of clinical gastroenterology.
[187] R. Elston,et al. Segregation analysis of hereditary nonpolyposis colorectal cancer , 1986, Genetic epidemiology.
[188] W. Clark,et al. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. , 1985, The New England journal of medicine.
[189] H. Lynch,et al. Surveillance and Management of Patients at High Genetic Risk for Ovarian Carcinoma , 1982, Obstetrics and gynecology.
[190] W. Clark,et al. Precursor Lesions in Familial Melanoma: A New Genetic Preneoplastic Syndrome , 1978 .
[191] L. Strong. Genetic and environmental interactions , 1977, Cancer.
[192] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[193] J. Fraumeni,et al. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.
[194] R. Gorlin,et al. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. , 1960, The New England journal of medicine.